ACR-话题@MedSci

#ACR#

285篇内容 | 2290人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1400469, encodeId=50a4140046923, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：肿瘤浸润淋巴细胞（TIL）疗法挑战PD-1耐药性肺癌, objectType=article, longId=193170, objectId=53521931e076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53521931e076, replyNumber=0, likeNumber=72, createdTime=2020-05-01, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53521931e076, moduleTitle=AACR 2020：肿瘤浸润淋巴细胞（TIL）疗法挑战PD-1耐药性肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53521931e076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400468, encodeId=fc071400468d0, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：伯瑞替尼治疗MET异常NSCLC，ORR达30.5%, objectType=article, longId=193168, objectId=64ac1931686b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64ac1931686b, replyNumber=0, likeNumber=49, createdTime=2020-05-01, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64ac1931686b, moduleTitle=AACR 2020：伯瑞替尼治疗MET异常NSCLC，ORR达30.5%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64ac1931686b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400467, encodeId=9ac2140046e56, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：厄洛替尼±雷莫芦单抗一线治疗NSCLC EGFR突变III期研究的NGS下结果(RELAY研究), objectType=article, longId=193163, objectId=3f4219316311, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f4219316311, replyNumber=0, likeNumber=53, createdTime=2020-05-01, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f4219316311, moduleTitle=AACR 2020：厄洛替尼±雷莫芦单抗一线治疗NSCLC EGFR突变III期研究的NGS下结果(RELAY研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f4219316311)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400466, encodeId=d1051400466f6, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：拉罗替尼治疗TRK融合肿瘤的亚组分析, objectType=article, longId=193161, objectId=31991931618c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31991931618c, replyNumber=0, likeNumber=62, createdTime=2020-05-01, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31991931618c, moduleTitle=AACR 2020：拉罗替尼治疗TRK融合肿瘤的亚组分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31991931618c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400465, encodeId=96b014004650c, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：波奇替尼治疗NSCLC的EGFR 20ins的II期研究, objectType=article, longId=193160, objectId=a05f193160ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a05f193160ff, replyNumber=0, likeNumber=67, createdTime=2020-05-01, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a05f193160ff, moduleTitle=AACR 2020：波奇替尼治疗NSCLC的EGFR 20ins的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a05f193160ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400464, encodeId=7e0b140046482, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：Capmatinib治疗MET 14突变的NSCLC脑转移疗效, objectType=article, longId=193158, objectId=b7d619315856, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7d619315856, replyNumber=0, likeNumber=68, createdTime=2020-05-01, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7d619315856, moduleTitle=AACR 2020：Capmatinib治疗MET 14突变的NSCLC脑转移疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7d619315856)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400463, encodeId=24fd14004639b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：Durvalumab治疗III期不可切除NSCLC的吸烟状态亚组分析, objectType=article, longId=193155, objectId=a1ad1931551a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1ad1931551a, replyNumber=0, likeNumber=98, createdTime=2020-05-01, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1ad1931551a, moduleTitle=AACR 2020：Durvalumab治疗III期不可切除NSCLC的吸烟状态亚组分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1ad1931551a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400462, encodeId=55c2140046254, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：STK11和KEAP1突变影响K药一线治疗PDL1阳性患者（Keynote 042研究）, objectType=article, longId=193109, objectId=bc64193109cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc64193109cc, replyNumber=0, likeNumber=134, createdTime=2020-04-30, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc64193109cc, moduleTitle=AACR 2020：STK11和KEAP1突变影响K药一线治疗PDL1阳性患者（Keynote 042研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc64193109cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400461, encodeId=fd26140046147, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：豪森药业阿美替尼用于EGFR突变耐药的NSCLC患者结果公布, objectType=article, longId=193108, objectId=28561931082d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28561931082d, replyNumber=0, likeNumber=73, createdTime=2020-04-30, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28561931082d, moduleTitle=AACR 2020：豪森药业阿美替尼用于EGFR突变耐药的NSCLC患者结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28561931082d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400460, encodeId=80a814004603f, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：大样本NSCLC中的FGFR基因突变结果发布, objectType=article, longId=193107, objectId=ee7719310e83, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee7719310e83, replyNumber=0, likeNumber=65, createdTime=2020-04-30, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee7719310e83, moduleTitle=AACR 2020：大样本NSCLC中的FGFR基因突变结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee7719310e83)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400459, encodeId=b87a1400459b2, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=AACR 2020：卡瑞利珠单抗+阿帕替尼治疗SCLC（小细胞肺癌）的II期研究, objectType=article, longId=193104, objectId=5d7319310411, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d7319310411, replyNumber=0, likeNumber=78, createdTime=2020-04-30, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d7319310411, moduleTitle=AACR 2020：卡瑞利珠单抗+阿帕替尼治疗SCLC（小细胞肺癌）的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d7319310411)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400458, encodeId=10e414004589a, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=2020 ACR指南：风湿性和肌肉骨骼疾病生殖健康的管理, objectType=article, longId=189066, objectId=efdc189066ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efdc189066ec, replyNumber=0, likeNumber=25, createdTime=2020-03-02, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efdc189066ec, moduleTitle=2020 ACR指南：风湿性和肌肉骨骼疾病生殖健康的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efdc189066ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400457, encodeId=ae0e140045e19, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=Int J Biol Macromol：可溶性β-葡聚糖销售可改善阴道白色念珠菌的感染, objectType=article, longId=188694, objectId=ac9118869420, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac9118869420, replyNumber=0, likeNumber=54, createdTime=2020-02-25, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac9118869420, moduleTitle=Int J Biol Macromol：可溶性β-葡聚糖销售可改善阴道白色念珠菌的感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac9118869420)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400456, encodeId=2cc6140045626, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=Macromol Biosci：Ti-VH@PVA笼或可用于预防脊柱外科手术后的感染, objectType=article, longId=188422, objectId=764b188422ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=764b188422ed, replyNumber=0, likeNumber=54, createdTime=2020-02-21, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=764b188422ed, moduleTitle=Macromol Biosci：Ti-VH@PVA笼或可用于预防脊柱外科手术后的感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=764b188422ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400455, encodeId=7ecb14004553c, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=2020 ACR/NKF共识声明：静脉注射碘造影剂在肾脏病患者中的应用, objectType=article, longId=188368, objectId=f0d71883687c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0d71883687c, replyNumber=0, likeNumber=24, createdTime=2020-02-20, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0d71883687c, moduleTitle=2020 ACR/NKF共识声明：静脉注射碘造影剂在肾脏病患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0d71883687c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400454, encodeId=1510140045419, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理, objectType=article, longId=186756, objectId=9d1f186e5607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d1f186e5607, replyNumber=0, likeNumber=0, createdTime=2020-01-27, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d1f186e5607, moduleTitle=2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d1f186e5607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400453, encodeId=50741400453bf, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=2019年EULAR/ACR系统性红斑狼疮分类标准解读, objectType=article, longId=185220, objectId=44e21852208a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44e21852208a, replyNumber=0, likeNumber=26, createdTime=2019-12-26, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44e21852208a, moduleTitle=2019年EULAR/ACR系统性红斑狼疮分类标准解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44e21852208a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400452, encodeId=b6e114004521e, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=Int J Biol Macromol：骨状氧化锆纳米陶瓷改性壳聚糖基多孔纳米复合材料可用作骨组织工程, objectType=article, longId=183764, objectId=f9cc183e64e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9cc183e64e0, replyNumber=0, likeNumber=93, createdTime=2019-11-30, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9cc183e64e0, moduleTitle=Int J Biol Macromol：骨状氧化锆纳米陶瓷改性壳聚糖基多孔纳米复合材料可用作骨组织工程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9cc183e64e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400451, encodeId=a5fe140045193, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=2019年ACR / ARP：Mallinckrodt公布Acthar凝胶（促肾上腺皮质激素注射液）治疗RA的全新数据, objectType=article, longId=182958, objectId=d98f1829587b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d98f1829587b, replyNumber=0, likeNumber=74, createdTime=2019-11-15, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d98f1829587b, moduleTitle=2019年ACR / ARP：Mallinckrodt公布Acthar凝胶（促肾上腺皮质激素注射液）治疗RA的全新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d98f1829587b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1400450, encodeId=7387140045029, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, objectTitle=2019年ACR / ARP：COAST-X研究展示了ixekizumab治疗非放射性轴性脊柱关节炎的积极数据, objectType=article, longId=182957, objectId=980118295e5b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=980118295e5b, replyNumber=0, likeNumber=0, createdTime=2019-11-15, rootId=0, userName=10518094zz, userId=19792261142, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=980118295e5b, moduleTitle=2019年ACR / ARP：COAST-X研究展示了ixekizumab治疗非放射性轴性脊柱关节炎的积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=980118295e5b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACR

2020-05-29

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：肿瘤浸润淋巴细胞（TIL）疗法挑战PD-1耐药性肺癌

2020-05-01

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：伯瑞替尼治疗MET异常NSCLC，ORR达30.5%

2020-05-01

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：厄洛替尼±雷莫芦单抗一线治疗NSCLC EGFR突变III期研究的NGS下结果(RELAY研究)

2020-05-01

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：拉罗替尼治疗TRK融合肿瘤的亚组分析

2020-05-01

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：波奇替尼治疗NSCLC的EGFR 20ins的II期研究

2020-05-01

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：Capmatinib治疗MET 14突变的NSCLC脑转移疗效

2020-05-01

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：Durvalumab治疗III期不可切除NSCLC的吸烟状态亚组分析

2020-05-01

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：STK11和KEAP1突变影响K药一线治疗PDL1阳性患者（Keynote 042研究）

2020-04-30

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：豪森药业阿美替尼用于EGFR突变耐药的NSCLC患者结果公布

2020-04-30

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：大样本NSCLC中的FGFR基因突变结果发布

2020-04-30

10518094zz (审核中...)

前往app查看评论内容

#ACR#

AACR 2020：卡瑞利珠单抗+阿帕替尼治疗SCLC（小细胞肺癌）的II期研究

2020-04-30

10518094zz (审核中...)

前往app查看评论内容

#ACR#

2020 ACR指南：风湿性和肌肉骨骼疾病生殖健康的管理

2020-03-02

10518094zz (审核中...)

前往app查看评论内容

#ACR#

Int J Biol Macromol：可溶性β-葡聚糖销售可改善阴道白色念珠菌的感染

2020-02-25

10518094zz (审核中...)

前往app查看评论内容

#ACR#

Macromol Biosci：Ti-VH@PVA笼或可用于预防脊柱外科手术后的感染

2020-02-21

10518094zz (审核中...)

前往app查看评论内容

#ACR#

2020 ACR/NKF共识声明：静脉注射碘造影剂在肾脏病患者中的应用

2020-02-20

10518094zz (审核中...)

前往app查看评论内容

#ACR#

2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理

2020-01-27

10518094zz (审核中...)

前往app查看评论内容

#ACR#

2019年EULAR/ACR系统性红斑狼疮分类标准解读

2019-12-26

10518094zz (审核中...)

前往app查看评论内容

#ACR#

Int J Biol Macromol：骨状氧化锆纳米陶瓷改性壳聚糖基多孔纳米复合材料可用作骨组织工程

2019-11-30

医者仁心 (审核中...)

前往app查看评论内容

#ACR#

2019年ACR / ARP：Mallinckrodt公布Acthar凝胶（促肾上腺皮质激素注射液）治疗RA的全新数据

2019-11-15

10518094zz (审核中...)

前往app查看评论内容

#ACR#

2019年ACR / ARP：COAST-X研究展示了ixekizumab治疗非放射性轴性脊柱关节炎的积极数据

2019-11-15

科室
- - 订阅+
  - 更多科室
工具
服务